Follow-up from the RAPID trial: involved-field radiotherapy versus no further treatment in HL
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2025-01-14
Просмотров: 96
Описание:
John Radford, MB ChB, The University of Manchester and Christie NHS Foundation Trust, Manchester, UK, comments on the long-term follow-up data from the RAPID trial (NCT00943423) of positron emission tomography (PET)-directed therapy for Hodgkin lymphoma. After a median follow-up of 16 years, there was no difference in survival between patients who received involved-field radiotherapy versus those who did not. Prof. Radford highlights that a positive PET scan is associated with a poor prognosis, and that radiotherapy may only be necessary for high-risk patients. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
